Prosecution Insights
Last updated: May 29, 2026

Hemanext Inc.

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (80%)
§102 only1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GURTOWSKI, RICHARD C 1 71.9% +38.9%
SPENCER, ANDREA LYNNE MORRIS 1 25.0% +0.0%
BARRON, SEAN C 1 53.5% +30.9%
FOX, ALLISON M 1 71.5% +36.1%
MIANO, JOSEPH PAUL 1 37.9% +63.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17954138 Methods for the Storage of Whole Blood, and Compositions Thereof SPENCER, ANDREA LYNNE MORRIS 25d overdue

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17241648 Methods for the Storage of Whole Blood, and Compositions Thereof MIANO, JOSEPH PAUL 107d overdue
17639823 Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide FOX, ALLISON M 8d overdue
18452051 Reinforced Gas Permeable Blood Storage Bags, and Methods of Preparation Thereof GURTOWSKI, RICHARD C 16d
17772947 Anaerobic Blood Storage and Pathogen Inactivation Method BARRON, SEAN C 29d

Top Art Units

Art UnitApps
1631 2
1773 1
1653 1
1633 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18452051 Reinforced Gas Permeable Blood Storage Bags, and Methods of Preparation Thereof GURTOWSKI, RICHARD C 1773 §103 Non-Final OA 16d Pending Aug 18, 2023
17954138 Methods for the Storage of Whole Blood, and Compositions Thereof SPENCER, ANDREA LYNNE MORRIS 1631 §103 Non-Final OA 25d overdue Pending Sep 27, 2022
17772947 Anaerobic Blood Storage and Pathogen Inactivation Method BARRON, SEAN C 1653 §103 Final Rejection 29d Pending Apr 28, 2022
17639823 Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide FOX, ALLISON M 1633 §103 Non-Final OA 8d overdue Pending Mar 02, 2022
17241648 Methods for the Storage of Whole Blood, and Compositions Thereof MIANO, JOSEPH PAUL 1631 §102 Non-Final OA 107d overdue Pending Apr 27, 2021

Managing Hemanext Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month